CDH6 and neoplasm: A single dose of 10 mg/kg CUSP06 significantly regressed the tumor growth in a CDH6-high, PARP inhibitor-resistant ovarian PDX model (LD1-1588, CDH6 H-score = 280) compared to isotype-ADC control (p < 0.05).